Table 5:
Study [ref] |
Country Year of Publication |
Population (% men, mean age) |
Follow-up (years) | Outcomes (events) |
Measurement | Adjusted HR (95% CI)* |
Ethnicity and/or other comments |
---|---|---|---|---|---|---|---|
FHS64 | USA 2016 | 3,486 (49%, 50y) | 8 | CHD events (59) CV events (107) |
Agatston (L1-L4) |
1.95 (1.3, 3.0) 1.50 (1.1, 2.05) |
NR |
MESA89 | USA 2014 | 1,974 (50%, 65y) | 5.5 | CHD events (50) CV events (83) CVD (30) |
Agatston percentiles (L2-L5) |
4.06 (1.8, 7.8) 4.00 (1.9, 5.5) 7.83 (2.2, 28.3) |
40.2% Non-Hispanic White, 25.7% Hispanic, 20.9% African-American, 13.2% Chinese |
CARDIA 79 | USA 2021 | 3,011 (44.9%, 50y) | 8 | CHD events (55) CV events (106) |
Agatston | 1.49 (1.13, 1.98) 1.45 (1.18, 1.77) |
50% Black, 50% White |
San Diego73 | USA 2011 | 4,544 (57%, 57y) | 7.8 | CVD (40) |
Volume (L1-L4) |
1.62 (0.9, 3.0) | NR |
MESA 155 | USA 2016 | 997 (52%, 66y) | 9 | CHD events (77) CV events (118) |
Volume | 1.10 (0.95,1.3)^ 1.14 (1.00,1.32)^ |
47% European, 24% Hispanic, 16% African, 13% Chinese |
AAC indicates abdominal aortic calcification; NR, not reported (race/ethnicity); CHD, coronary heart disease; CV, cardiovascular; FHS, Framingham Heart Study; MESA, Multi-Ethnic Study of Atherosclerosis; CARDIA, The Coronary Artery Risk Development in Young Adults Study.